Neuro

Rapid Medical™ Gains Approval in China for the World’s Only Adjustable Thrombectomy Device

YOKNEAM, Israel & MIAMI–(BUSINESS WIRE)–Rapid Medical™, a leading developer of advanced neurovascular devices, announced Chinese approval for its TIGERTRIEVER revascularization device. With this milestone of National Medical Product Administration (NMPA) approval, TIGERTRIEVER becomes the first device to offer patient-specific solutions for removing blood clots from the brain to advance the treatment of ischemic […]

ACTIMIS Post-hoc Results on Imaging Stroke Data Using Artificial Intelligence Reinforces Glenzocimab Mode of Action in Stroke Patients

PARIS–(BUSINESS WIRE)–Acticor Biotech, (ISIN: FR0014005OJ5 – ALACT), a clinical stage biopharmaceutical company developing glenzocimab, an innovative drug for the treatment of cardiovascular emergencies, announced today the results of its collaboration with Brainomix Limited, to further explore the imaging data using Artificial Intelligence (AI) from its phase 1b/2a ACTIMIS study. The ACTIMIS […]

For Realizing Vision of ZERO Cerebro-Cardiovascular Events, OMRON Healthcare Sponsors First Annual Meeting of AF Screen International Collaboration

KYOTO, Japan, Aug. 29, 2023 /PRNewswire/ — OMRON Healthcare Co., Ltd. (hereinafter referred to as the Company) based in Muko, Kyoto Prefecture, has announced the official sponsorship of the first annual meeting of the AF Screen International Collaboration, a collaborative group that was established to promote discussion and research about screening for unknown […]

Imperative Care Announces Positive Real-World Data Demonstrating the Clinical Benefits of the Zoom Stroke Solution in Large Vessel and Distal Vessel Occlusions

CAMPBELL, Calif.–(BUSINESS WIRE)–Imperative Care, a medical technology company developing connected innovations to elevate care for people affected by stroke and other ischemic diseases, today announced that new data from studies evaluating the Zoom Stroke Solution were presented at the Society of NeuroInterventional Surgery (SNIS) 2023 20th Annual Meeting in San […]

MicroVention Announces 5-Year Clinical Trial Data and Size Additions for its WEB Aneurysm Embolization System; WEB is Most Well-Studied Intrasaccular Device Available Today

SAN DIEGO & ALISO VIEJO, Calif.–(BUSINESS WIRE)–MicroVention, Inc., a global neurovascular company and wholly owned subsidiary of Terumo Corporation, announced the publication of WEB-IT 5-year follow-up data and the addition of two sizes to its WEB Aneurysm Embolization System. With this five-year clinical trial data just recently published, WEB is the most well […]

Route 92 Medical Announces Publication of a Retrospective Study in the Interventional Neuroradiology Journal

SAN MATEO, Calif., July 31, 2023 (GLOBE NEWSWIRE) — Route 92 Medical, Inc., a privately held medical technology company dedicated to improving outcomes for patients undergoing neurovascular intervention, today announced the publication of a first-in-human study featuring the FreeClimb® 70 reperfusion system in the Interventional Neuroradiology Journal. The study, conducted across five U.S. centers and one international […]

Aidoc Introduces the First and Only AI-Powered Solution to Identify Suspected Posterior and Anterior Large and Medium Vessel Occlusions

NEW YORK, July 31, 2023 /PRNewswire/ — Aidoc, a pioneering force in clinical AI, announced today the launch of its revolutionary Full Brain Solution. This new solution will significantly expand the anatomy analyzed by AI to identify suspected strokes, allowing for identification and care coordination of patients with medium vessel occlusions […]

Imperative Care Announces Multiple Poster Presentations on the Zoom Stroke Solution at the Society of NeuroInterventional Surgery 20th Annual Meeting

CAMPBELL, Calif.–(BUSINESS WIRE)–Imperative Care, a medical technology company developing connected innovations to elevate care for people affected by stroke and other ischemic diseases, today announced that new data from studies evaluating the Zoom Stroke Solution for the treatment of ischemic stroke will be presented at the Society of NeuroInterventional Surgery […]

Hyperfine, Inc. Launches Observational Study to Define New Imaging Paradigm in Stroke Care

GUILFORD, Conn.–(BUSINESS WIRE)– Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking medical device company that created the Swoop® system, the world’s first FDA-cleared portable magnetic resonance brain imaging system, has announced the commencement of an international, multi-site observational study, ACTION PMR (ACuTe Ischemic strOke detectioN with Portable MR). To support its acute stroke care initiatives, […]